We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Urine Test for Tuberculosis Needs Improving

By LabMedica International staff writers
Posted on 17 Aug 2011
A noninvasive urinary assay for tuberculosis (TB) is not accurate enough to be used for routine diagnosis of active tuberculosis. More...


The assay works by detecting the heat-stable glycolipid that is present in the cell walls of Mycobacterium tuberculosis and released from active or degrading cells during an infection.

A meta-analysis of and systematic review was conducted on the use of the lipoarabinomannan (LAM) urinary assay for the diagnosis of active TB. Scientists pooled data from nine studies that compared LAM urine testing to an accepted reference, such as positive culture or nucleic acid amplification for TB. Included were trials from Sweden, Ethiopia, Tanzania, Zimbabwe, South Africa, and India, with a total of close to 3,000 people.

In seven studies that only included microbiologically confirmed cases of TB, LAM sensitivity ranged from 13% to 93%, and specificity was 87% to 99%. Sensitivity also varied widely in two additional analyses that counted clinically confirmed cases as either positive or negative for TB. The team stated the assay was more accurate in HIV-positive patients. In that group, its sensitivity for TB was 3% to 53% higher than in HIV-negative individuals, with similar specificity. Sensitivity was highest when immunosuppression was advanced, in which case there might be more LAM in the urine for detection.

Dick Menzies, MD, a lead author of the study from the Montreal Chest Clinic (Montreal, QC, Canada), said, "The LAM urine assay has many characteristics which make it a potentially useful rule-in TB diagnostic, but this review found inadequate sensitivity to use the LAM assay for the diagnosis of TB in unselected cohorts." However, further studies are warranted to evaluate the added value of the LAM assay, known as Clearview TB ELISA (Inverness Medical Innovations; Princeton, NJ, USA) in the diagnosis of active TB. It is especially important for individuals with advanced HIV and in children as well as to assess newer versions of this test with technical advances compared to those in the study. The review was published online on July 4, 2011, in the European Respiratory Journal.

Related Links:

Montreal Chest Clinic
Inverness Medical Innovations



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: The smart microscope can predict the onset of misfolded protein aggregation, a hallmark of neurodegenerative diseases (Photo courtesy of EPFL)

Self-Driving Microscope Tracks and Analyzes Misfolded Protein Aggregation in Real Time

The accumulation of misfolded proteins in the brain is central to the progression of neurodegenerative diseases like Huntington’s, Alzheimer’s, and Parkinson’s. Yet to the human eye, proteins that are... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.